MetLife Investment Management’s National Instruments Corp NATI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-79,615
Closed -$4.75M 2902
2023
Q3
$4.75M Sell
79,615
-3,444
-4% -$202K 0.04% 430
2023
Q2
$4.77M Buy
83,059
+2,312
+3% +$133K 0.03% 474
2023
Q1
$4.23M Sell
80,747
-2,141
-3% -$107K 0.03% 549
2022
Q4
$3.06M Sell
82,888
-2,759
-3% -$108K 0.02% 719
2022
Q3
$3.23M Sell
85,647
-343
-0.4% -$13K 0.03% 650
2022
Q2
$2.69M Buy
85,990
+686
+0.8% +$24.3K 0.02% 777
2022
Q1
$3.46M Buy
85,304
+21,393
+33% +$863K 0.02% 745
2021
Q4
$2.79M Buy
63,911
+26
+0% +$1.1K 0.02% 712
2021
Q3
$2.51M Sell
63,885
-1,875
-3% -$78.4K 0.02% 753
2021
Q2
$2.78M Sell
65,760
-2,220
-3% -$93.5K 0.02% 720
2021
Q1
$2.94M Sell
67,980
-3,839
-5% -$169K 0.03% 687
2020
Q4
$3.16M Sell
71,819
-3,433
-5% -$128K 0.03% 594
2020
Q3
$2.69M Buy
75,252
+5,454
+8% +$198K 0.03% 592
2020
Q2
$2.7M Buy
69,798
+2,092
+3% +$79.1K 0.03% 578
2020
Q1
$2.24M Hold
67,706
0.03% 562
2019
Q4
$2.87M Sell
67,706
-1,331
-2% -$55.7K 0.03% 648
2019
Q3
$2.9M Buy
69,037
+2,631
+4% +$113K 0.03% 620
2019
Q2
$2.79M Sell
66,406
-2,110
-3% -$90K 0.03% 657
2019
Q1
$3.04M Sell
68,516
-121
-0.2% -$5.49K 0.03% 609
2018
Q4
$3.11M Sell
68,637
-161
-0.2% -$7.51K 0.04% 527
2018
Q3
$3.33M Buy
68,798
+1,179
+2% +$53.7K 0.03% 602
2018
Q2
$2.84M Buy
67,619
+478
+0.7% +$21.2K 0.03% 654
2018
Q1
$3.4M Sell
67,141
-692
-1% -$33.7K 0.04% 532
2017
Q4
$2.82M Buy
+67,833
New +$2.96M 0.03% 668

Other funds holding NATI

MetLife Investment Management's NATI Position: Q4 2023 in Review

MetLife Investment Management sold out of National Instruments Corp (NATI) in Q4 2023, closing a stake of 79,615 shares — an estimated $4.75M sold.

MetLife Investment Management first reported a position in NATI in Q4 2017 and held it in 24 quarters. The position peaked at $4.77M in Q2 2023. 3 funds tracked by Wall St. Rank hold NATI as of Q4 2023.

  • MetLife Investment Management reported no remaining National Instruments Corp position as of Q4 2023 after selling out during the quarter.
  • MetLife Investment Management sold 79,615 National Instruments Corp shares in Q4 2023, an estimated $4.75M.
  • MetLife Investment Management first reported a position in National Instruments Corp in Q4 2017 and held it in 24 quarters.
  • MetLife Investment Management's National Instruments Corp position peaked at $4.77M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held National Instruments Corp as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.